HZHai-Yan Zhang

Hai-Yan Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hai-Yan Zhang has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Dinghong Xiao

    Department of 2nd Gastroenterology, Longhua Hospital Shanghai University of Traditional Chinese Medicine, No. 725, Wanping South Road, Xuhui District, Shanghai 200032, China

    1 shared publication
  • Lianjun Xing

    Longhua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai, China

    1 shared publication
  • Lin He

    Department of 2nd Gastroenterology, Longhua Hospital Shanghai University of Traditional Chinese Medicine, No. 725, Wanping South Road, Xuhui District, Shanghai 200032, China

    1 shared publication
  • Xiao Yv

    Department of 2nd Gastroenterology, Longhua Hospital Shanghai University of Traditional Chinese Medicine, No. 725, Wanping South Road, Xuhui District, Shanghai 200032, China

    1 shared publication
  • Zhidong Liu

    Department of Internal Medicine of Traditional Chinese Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China

    1 shared publication

Latest Publications

  • Open Access

    The Oral–Gastric Microbial Axis in Gastric Cancer: Mechanisms Underlying Development and Progression

    by Lin He, Xiao Yu, Ding-Hong Xiao, Hai-Yan Zhang, Lian-Jun Xing, Zhi-Dong Liu

    The etiology of gastric cancer (GC) is increasingly defined by the complex interplay within the oral-gastric microbial axis. This conceptual shift extends beyond the classical Helicobacter pylori (H. pylori) model. Instead, it encompasses a broader polymicrobial network. Mechanisms underlying ectopic colonization of oral pathobionts are examined alongside their synergistic contributions to mucosal dysbiosis. Remodeling of the tumor microenvironment is discussed through the analysis of critical functional modules, including biofilm formation, metabolic reprogramming, and immune dysregulation. Carcinogenesis is reportedly promoted by specific genotoxic metabolites and perpetuation of chronic inflammation. Diagnostic capabilities are evaluated with a focus on noninvasive biomarkers, where integration of artificial intelligence for risk stratification is identified as a transformative tool for early detection. Furthermore, therapeutic perspectives are expanded by evidence linking microbial composition to the efficacy of immune checkpoint inhibitors and chemotherapy. Strategies for prevention and treatment are proposed based on restoration of microbial homeostasis. Collectively, a roadmap for translating microbiome research into personalized clinical practice for gastrointestinal malignancies is provided by this review.